Figure_3.tif (393.68 kB)

Immunogenicity of epitope-based DNA vaccines in wild-type Balb/c mice.

Download (0 kB)
posted on 29.03.2013 by Federico Gabrielli, Roberto Salvi, Chiara Garulli, Cristina Kalogris, Serena Arima, Luca Tardella, Paolo Monaci, Serenella M. Pupa, Elda Tagliabue, Maura Montani, Elena Quaglino, Lorenzo Stramucci, Claudia Curcio, Cristina Marchini, Augusto Amici

The antitumor protection afforded by each plasmid, electroporated 21 and 7 days before a lethal rat HER2-positive TUBO cell challenge, is shown both as tumor-free survival (a) and tumor size (b).